Thursday, May 06, 2021 7:31:22 PM
If Dr. Javitt has applied for eua, then it's up to the FDA. We don't know what else was required by the FDA. The fact is both companies are working on commercialization of zyesami. So give it a rest on criticizing Dr. Javitt. Have you ever worked for pharmaceutical company? Have you ever worked at obtaining approval of a drug by the FDA? FDA & Dr. Javitt timeline are different from your timeline. Stay calm and collective. All the ranting and raging will not speed things up. But it'll increase your blood pressure......
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM